Bio Essence (BIOE) EBIAT (2020 - 2025)
Bio Essence has reported EBIAT over the past 6 years, most recently at $1.0 million for Q4 2025.
- Quarterly results put EBIAT at $1.0 million for Q4 2025, up 3833.58% from a year ago — trailing twelve months through Dec 2025 was $896197.0 (up 168.47% YoY), and the annual figure for FY2025 was $896197.0, up 168.47%.
- EBIAT for Q4 2025 was $1.0 million at Bio Essence, up from $12998.0 in the prior quarter.
- Over the last five years, EBIAT for BIOE hit a ceiling of $1.0 million in Q4 2025 and a floor of -$1.2 million in Q3 2024.
- Median EBIAT over the past 5 years was -$163865.5 (2021), compared with a mean of -$90078.9.
- Biggest five-year swings in EBIAT: plummeted 280.98% in 2024 and later skyrocketed 3833.58% in 2025.
- Bio Essence's EBIAT stood at -$90634.0 in 2021, then skyrocketed by 175.76% to $68664.0 in 2022, then surged by 444.08% to $373588.0 in 2023, then tumbled by 107.38% to -$27563.0 in 2024, then skyrocketed by 3833.58% to $1.0 million in 2025.
- The last three reported values for EBIAT were $1.0 million (Q4 2025), $12998.0 (Q3 2025), and $59864.0 (Q2 2025) per Business Quant data.